Ahrens et al (2007) induced tolerance in five CVID patients with a history of anaphylaxis by infusing IgA-depleted IVIG preparations that contained only small amounts of IgA, until IgA antibody activity was decreased significantly or became undetectable. The gene discussed is CD79A; the disease is common variable immunodeficiency.